Nobody books this on the first click. This is the most researched decision in mental health. Patients read for weeks and ask their psychiatrist before they call. Marketing that ignores that just buys expensive clicks.
Book a 30-minute callYou can run Google Ads for a ketamine or Spravato clinic. In US campaigns, Google lets you name a prescription drug such as Spravato in the ad and on the landing page, within the law, but only certified advertisers can target drug names as keywords, so the campaign is built on searches that don't use them. Fill The Lobby holds page and ad to one claim set, runs Spravato and IV as separate campaigns, and argues the appeal when something is pulled. Ad spend goes from your own account straight to Google.
People searching ketamine therapy are frightened and curious in equal measure. The clinic that answers the questions gets the consult — the one that shouts about availability gets ignored.
One is FDA-approved for two depression indications in adults, is REMS-bound and is given only in certified settings. The other is approved as an anesthetic and, as the FDA restated in June 2026, not for any psychiatric disorder, and it is far less understood. Running them through one funnel wastes both.
A psychiatrist who refers once refers again. We build the pathway that makes referring easy, and use paid search to catch the people arriving on their own.
No outcome promises. No before-and-afters. No implying a treatment is approved for something it isn't. This category gets scrutinized, and we write like it.
A booked consult that no-shows costs more here than almost anywhere else. Confirmations, reminders and a real human path if they hesitate.
The clinics that win are the ones that teach first.
No patient testimonials. No outcome claims. BAA signed before any data moves.
Spravato can only be given in a healthcare setting certified under its REMS, a safety program the FDA requires, and every patient is monitored onsite after every dose. Those rules set your capacity, your booking page and what your ads can say, so Spravato marketing starts from them. The full checklist and the forms are in our guide to Spravato REMS requirements.
Under the Spravato REMS, an outpatient center needs a prescriber onsite during dosing and monitoring, healthcare providers and a pulse oximeter to monitor patients, an authorized representative who enrolls the setting, and written processes with trained staff. A setting that isn't certified can't receive Spravato, so until the REMS confirms you, there is nothing to book. A launch plan starts from that date, not from the day the ad account opens.
The REMS requires monitoring for at least two hours after each dose, and until sedation, dissociation and respiratory depression have resolved. The prescribing information starts treatment-resistant depression at twice a week for the first four weeks. So each new patient takes two long, monitored visits a week for a month, with a prescriber onsite. We pace ad spend to the monitored chairs and staff you have, not to a flat monthly number, and keep in touch with anyone who can't start yet rather than leaving them waiting in silence.
Every outpatient is enrolled in the REMS on a Patient Enrollment Form completed with a healthcare provider, and the prescriber's part asks for pre-existing medical and psychiatric conditions and current medications. That is intake, done with a provider. The form on your site or behind an ad takes contact details and a preferred time, and nothing about health.
The Outpatient Healthcare Setting Enrollment Form says a certified setting's name, location and phone number go on a location finder for healthcare professionals and patients seeking Spravato, unless you call the REMS at 1-855-382-6022 to opt out. Treat it like any other listing: give it a number that gets answered, and a name and address that match your website and your Google Business Profile.
For US campaigns, Google's restricted drug terms policy lets advertisers use prescription drug names in ads and landing pages without certification, within the law, but only certified advertisers can target them as keywords. Google says not to apply for a certification that doesn't match your business, and none of its examples describes an in-office treatment center. LegitScript certification, which Google and Meta rely on for telehealth providers and online pharmacies, is generally not open to in-person-only clinics that don't prescribe through telemedicine or take card-not-present payments for prescription drugs. So the Google campaign runs on searches that don't use the drug name. Google also judges from your ads, site and services whether you are promoting online prescribing, and errs on the side of caution: if your site offers virtual visits that can end in a prescription, that service needs LegitScript and Google certification before it can be advertised. On Meta, the line is whether an ad promotes a prescription drug. Meta runs those ads only for LegitScript-certified advertisers and for manufacturers that pass its own review, once it has authorized them, so an in-office center without LegitScript certification can't run Meta ads that promote Spravato. Ads that only educate about a prescription drug need no written authorization.
The prescribing information indicates Spravato for treatment-resistant depression in adults, alone or with an oral antidepressant, and for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, alongside an oral antidepressant. It also says Spravato's effectiveness in preventing suicide or reducing suicidal ideation or behavior has not been demonstrated. Ads and pages say no more than the label does, and an IV ketamine page never borrows Spravato's approval. Johnson & Johnson's communications guide for treatment centers says to include the indications, limitations of use and Important Safety Information when you communicate about Spravato, and that using its materials gives you no right or license to its logos, trademarks or images.
Sources, checked 8 October 2026: FDA REMS@FDA listing for Spravato (REMS last updated 24 June 2026), the REMS Program Overview, the Outpatient Healthcare Setting Enrollment Form and Patient Enrollment Form, the Spravato prescribing information on DailyMed, Google's restricted drug terms, prescription drug services and healthcare and medicines policies, Meta's drugs and pharmaceuticals ad standards, LegitScript's healthcare certification FAQ, and Johnson & Johnson's Digital and Traditional Media Communications FAQ for Spravato treatment centers (October 2025).
We built and run our own clinical platforms — 200+ clinicians, patients in 20+ countries — and we spend our own money on these exact ads every day. Fill The Lobby is that engine, pointed at your practice.
Ketamine sits in the part of Google's policy where repeated disapprovals can escalate, after a warning, into a suspended account, and the review reads your landing page as well as your ad. A careful ad pointing at a page that talks about relief can be pulled for the page. So the claim set is identical on both, Spravato and IV run in separate campaigns rather than sharing one, so a decision against a Spravato ad is not automatically a decision against the IV ads, and the appeal is our job rather than a screenshot forwarded to you.
Most agencies meet this policy for the first time on your account, and you pay for their education in downtime. We have argued policy with Google using our own money, on our own platforms, before anyone let us near your budget. When something gets pulled, you hear what happened and what we changed, the same week it happened.
Spravato means at least two hours of monitoring after dosing, no driving until the next day after a restful sleep, and twice a week to start. If the first time a patient hears that is at the consult, you paid for a consult and a cancellation. Spravato marketing that leaves the logistics out books people who cannot do the schedule. So the session length, the driving rule and the early frequency go in the ad and on the booking page, before anyone takes a slot on your calendar.
That turns people away on purpose, and the booked number looks smaller for it. We would rather lose someone at the ad than in your chair, because a consult that ends at the logistics costs you the slot, the staff hour and the follow-up attached to it. If you would rather see the bigger number on the report, this is the wrong argument to have with us.
The way we structure and run Google Ads for medical practices does not change much between specialties; what changes here is how narrow the buy has to be, and how much of your page the reviewer reads before deciding. Somebody who has been reading for three weeks is not closed by one reply and then silence, which is why patient follow-up in this category runs on weeks rather than a two-day sequence written for a different specialty. None of it survives a click that lands on a brochure, so the booking pages carry the monitoring time, the driving rule and the cash-pay answer before anyone picks a slot. The full eight, and how they hand off to each other, are laid out under what we do. Retention here means a treatment course completed as the prescriber planned it, not patients chased back, so the number to watch is the missed session that breaks a course, which the patient retention calculator counts. All of it maps onto the seven leaks we look for in week one.
Searches like “ketamine therapy austin” that name a city add up to the most in Texas, California and Colorado. “Ketamine therapy austin” gets about 700 a month at around $6 a click, and “ketamine therapy denver” about 600 (Ahrefs, US, September 2026). Our state pages list the searches and click costs for every city where they can be measured, so you can see the demand before you choose where to advertise. Those figures measure demand, not keywords you can buy: only certified advertisers can bid on prescription drug names, so the campaign itself runs on searches that don't use them.
Questions
Reviewed October 2026.